65 filings
8-K
REVB
Revelation Biosciences, Inc.
26 Aug 24
Entry into a Material Definitive Agreement
4:25pm
8-K
REVB
Revelation Biosciences, Inc.
19 Aug 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
REVB
Revelation Biosciences, Inc.
9 Aug 24
Results of Operations and Financial Condition
4:24pm
8-K
REVB
Revelation Biosciences, Inc.
2 Aug 24
Other Events
4:11pm
8-K
REVB
Revelation Biosciences, Inc.
24 Jun 24
Other Events
4:28pm
8-K
pghr28g rs3w
16 May 24
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
ctg97kjwdda5l9z
10 May 24
Results of Operations and Financial Condition
4:57pm
8-K
7nrletvv
22 Mar 24
Results of Operations and Financial Condition
4:22pm
8-K
mf4c91 n7zhwr7w4
11 Mar 24
Regulation FD Disclosure
9:53pm
8-K
f0g06ul 9hisl
8 Feb 24
Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering
4:01pm
8-K
e1xngqlyt8qjixjpk6
30 Jan 24
Developing innovative therapeutics to address unmet needs Corporate Presentation / January 2024 www.revbiosciences.com
5:21pm
8-K
i5m 4b245
23 Jan 24
Material Modifications to Rights of Security Holders
4:18pm
8-K
d1xxdvvz cr
22 Jan 24
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
7wqpwx5mfxain8q sp
13 Nov 23
Results of Operations and Financial Condition
4:30pm
8-K
d4ll1yve4g9f o5
12 Oct 23
Developing innovative therapeutics to address unmet needs Corporate Presentation / October 2023 www.revbiosciences.com
4:26pm
8-K
oyrbmh2rvlpyicl1
2 Oct 23
Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors
4:24pm
8-K
bmkfkv08zqxai2
11 Aug 23
Results of Operations and Financial Condition
4:30pm
8-K
iyixv7 tpsshja26
11 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
pv6dz8otwvgpv
14 Jul 23
Submission of Matters to a Vote of Security Holders
4:51pm
8-K
p81jyu1k9dft 69wr
7 Jul 23
Amendments to Articles of Incorporation or Bylaws
4:07pm